Paper10429673
Targeted inhibition of intrinsic coagulation limits cerebral injury in stroke without increasing intracerebral hemorrhage.
Choudhri TF and 8 others. J Exp Med, 1999. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Targeted inhibition of intrinsic coagulation limits cerebral injury in stroke without increasing intracerebral hemorrhage. Papers, record 10429673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10429673
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cerebral Hemorrhage | Major topic |
| Ischemic Attack, Transient | Major topic |
| Animals | |
| Blood Coagulation | |
| Factor IXa | |
| Factor VIIIa | |
| Factor X | |
| Hemostasis | |
| Mice | |
| Vascular Patency |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Z01 NS002038 | Intramural NIH HHS | United States | K08NS002038 | PubMed and NIH | NIH RePORTER |
| R01 HL55397 | NHLBI NIH HHS | United States | R01HL055397 | PubMed and NIH | NIH RePORTER |
| R01 HL059488 | NHLBI NIH HHS | United States | R01HL059488 | PubMed and NIH | NIH RePORTER |
| K08 NS02038 | NINDS NIH HHS | United States | K08NS002038 | PubMed and NIH | NIH RePORTER |
| R01 HL055397 | NHLBI NIH HHS | United States | R01HL055397 | PubMed and NIH | NIH RePORTER |
| R01 HL59488 | NHLBI NIH HHS | United States | R01HL059488 | PubMed and NIH | NIH RePORTER |
| Z01NS002038 | NIH | NIH RePORTER |
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3535601 | Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. | Ann Intern Med | 1986 | https://conductscience.org/library/papers/3535601 | PubMed |
| 2 | 3336887 | Failure of heparin to prevent progression in progressing ischemic infarction. | Stroke | 1988 | https://conductscience.org/library/papers/3336887 | PubMed |
| 3 | 2478294 | PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. | Cell | 1989 | https://conductscience.org/library/papers/2478294 | PubMed |
| 4 | 2264071 | Natural history of progressive ischemic stroke in a population treated with heparin. | Stroke | 1990 | https://conductscience.org/library/papers/2264071 | PubMed |
| 5 | 1939660 | Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model. | J Clin Invest | 1991 | https://conductscience.org/library/papers/1939660 | PubMed |
| 6 | 1279433 | Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. | Nature | 1992 | https://conductscience.org/library/papers/1279433 | PubMed |
| 7 | 1481626 | The topography of microthrombi in ischemic brain infarct. | Acta Neurol Scand | 1992 | https://conductscience.org/library/papers/1481626 | PubMed |
| 8 | 8349806 | Extracellular proteolysis in the adult murine brain. | J Clin Invest | 1993 | https://conductscience.org/library/papers/8349806 | PubMed |
| 9 | 7690778 | Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. | J Clin Invest | 1993 | https://conductscience.org/library/papers/7690778 | PubMed |
| 10 | 8227367 | Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa. | J Clin Invest | 1993 | https://conductscience.org/library/papers/8227367 | PubMed |
| 11 | 7729008 | Enhanced preservation of orthotopically transplanted rat lungs by nitroglycerin but not hydralazine. Requirement for graft vascular homeostasis beyond harvest vasodilation. | Circ Res | 1995 | https://conductscience.org/library/papers/7729008 | PubMed |
| 12 | 7563451 | Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) | JAMA | 1995 | https://conductscience.org/library/papers/7563451 | PubMed |
| 13 | 7566088 | Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. | Nature | 1995 | https://conductscience.org/library/papers/7566088 | PubMed |
| 14 | 7477192 | Tissue plasminogen activator for acute ischemic stroke. | N Engl J Med | 1995 | https://conductscience.org/library/papers/7477192 | PubMed |
| 15 | 7477201 | Acute stroke--on the threshold of a therapy? | N Engl J Med | 1995 | https://conductscience.org/library/papers/7477201 | PubMed |
| 16 | 9806393 | Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass. | J Thorac Cardiovasc Surg | 1998 | https://conductscience.org/library/papers/9806393 | PubMed |
| 17 | 7495077 | Measurement of activated factor IX in factor IX concentrates: correlation with in vivo thrombogenicity. | Thromb Haemost | 1995 | https://conductscience.org/library/papers/7495077 | PubMed |
| 18 | 8578462 | The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: role of P-selectin and the P-selectin ligand, PSGL-1. | Thromb Haemost | 1995 | https://conductscience.org/library/papers/8578462 | PubMed |
| 19 | 8550836 | Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8550836 | PubMed |
| 20 | 8657211 | Thrombolytic therapy with streptokinase in acute ischemic stroke. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8657211 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38731959 | Circulating Blood Prognostic Biomarker Signatures for Hemorrhagic Cerebral Cavernous Malformations (CCMs). | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38731959 | PubMed |
| 35416530 | Novel contact-kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke. | Cell Mol Life Sci | 2022 | https://conductscience.org/library/papers/35416530 | PubMed |
| 34991418 | Factor IX(a) inhibitors: an updated patent review (2003-present). | Expert Opin Ther Pat | 2022 | https://conductscience.org/library/papers/34991418 | PubMed |
| 28725968 | Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke. | Acta Neuropathol | 2017 | https://conductscience.org/library/papers/28725968 | PubMed |
| 28580536 | Annexin A2 Plus Low-Dose Tissue Plasminogen Activator Combination Attenuates Cerebrovascular Dysfunction After Focal Embolic Stroke of Rats. | Transl Stroke Res | 2017 | https://conductscience.org/library/papers/28580536 | PubMed |
| 28378693 | Hematoma Expansion Following Intracerebral Hemorrhage: Mechanisms Targeting the Coagulation Cascade and Platelet Activation. | Curr Drug Targets | 2017 | https://conductscience.org/library/papers/28378693 | PubMed |
| 28275651 | Platelet microparticles: a biomarker for recanalization in rtPA-treated ischemic stroke patients. | Ann Clin Transl Neurol | 2017 | https://conductscience.org/library/papers/28275651 | PubMed |
| 22905983 | Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism. | J Thromb Haemost | 2012 | https://conductscience.org/library/papers/22905983 | PubMed |
| 22805877 | Next-generation antithrombotics in ischemic stroke: preclinical perspective on 'bleeding-free antithrombosis'. | J Cereb Blood Flow Metab | 2012 | https://conductscience.org/library/papers/22805877 | PubMed |
| 22420328 | The REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of acute coronary syndrome. | Future Cardiol | 2012 | https://conductscience.org/library/papers/22420328 | PubMed |
| 21909687 | Blood coagulation factor XII--a neglected player in stroke pathophysiology. | J Mol Med (Berl) | 2012 | https://conductscience.org/library/papers/21909687 | PubMed |
| 21901539 | [Acute ischemic stroke. New approaches to antithrombotic treatment]. | Nervenarzt | 2012 | https://conductscience.org/library/papers/21901539 | PubMed |
| 21645225 | The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model. | J Thromb Haemost | 2011 | https://conductscience.org/library/papers/21645225 | PubMed |
| 21142878 | A reversible aptamer improves outcome and safety in murine models of stroke and hemorrhage. | Oligonucleotides | 2011 | https://conductscience.org/library/papers/21142878 | PubMed |
| 20838739 | Nitrophorin 2, a factor IX(a)-directed anticoagulant, inhibits arterial thrombosis without impairing haemostasis. | Thromb Haemost | 2010 | https://conductscience.org/library/papers/20838739 | PubMed |
| 20657761 | Optical Microangiography: A Label Free 3D Imaging Technology to Visualize and Quantify Blood Circulations within Tissue Beds in vivo. | IEEE J Sel Top Quantum Electron | 2010 | https://conductscience.org/library/papers/20657761 | PubMed |
| 19714257 | Update on the physiology and pathology of factor IX activation by factor XIa. | Expert Rev Hematol | 2008 | https://conductscience.org/library/papers/19714257 | PubMed |
| 19414859 | Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite. | Blood | 2009 | https://conductscience.org/library/papers/19414859 | PubMed |
| 16672689 | Depolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism. | Blood | 2006 | https://conductscience.org/library/papers/16672689 | PubMed |
| 16533887 | Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. | J Exp Med | 2006 | https://conductscience.org/library/papers/16533887 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F10 | 2159 | PubTator's text mining | https://conductscience.org/library/genes/2159 | NCBI Gene |
| F2 | 2147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
| F9 | 2158 | PubTator's text mining | https://conductscience.org/library/genes/2158 | NCBI Gene |
| PLAT | 5327 | PubTator's text mining | https://conductscience.org/library/genes/5327 | NCBI Gene |
| PLG | 5340 | PubTator's text mining | https://conductscience.org/library/genes/5340 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10429673
GET https://conductscience.org/api/papers/v1/10429673/references?page=2